RENAL PELVIS CANCER
Clinical trials for RENAL PELVIS CANCER explained in plain language.
Never miss a new study
Get alerted when new RENAL PELVIS CANCER trials appear
Sign up with your email to follow new studies for RENAL PELVIS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug shows promise in early trial
Disease control OngoingThis early-stage trial tests a new drug called LY4101174 in people with advanced solid tumors, including bladder, breast, and lung cancers. The drug is an antibody-drug conjugate designed to target and kill cancer cells. The study will check if the drug is safe, tolerable, and ef…
Matched conditions: RENAL PELVIS CANCER
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Massive cancer registry aims to unlock genetic secrets of bladder cancer
Knowledge-focused OngoingThis study creates a large registry of people with and without urothelial cancer (bladder, ureter, or renal pelvis cancer) to learn how genes and lifestyle affect risk. Participants provide a saliva sample and fill out questionnaires. The goal is to improve prevention, diagnosis,…
Matched conditions: RENAL PELVIS CANCER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:53 UTC